{"id":"https://openalex.org/W2947740772","doi":"https://doi.org/10.3389/fcimb.2019.00174","title":"Characterization of the in vitro, ex vivo, and in vivo Efficacy of the Antimicrobial Peptide DPK-060 Used for Topical Treatment","display_name":"Characterization of the in vitro, ex vivo, and in vivo Efficacy of the Antimicrobial Peptide DPK-060 Used for Topical Treatment","publication_year":2019,"publication_date":"2019-05-28","ids":{"openalex":"https://openalex.org/W2947740772","doi":"https://doi.org/10.3389/fcimb.2019.00174","mag":"2947740772","pmid":"https://pubmed.ncbi.nlm.nih.gov/31192163","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6548878"},"language":"en","primary_location":{"id":"doi:10.3389/fcimb.2019.00174","doi":"https://doi.org/10.3389/fcimb.2019.00174","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fcimb.2019.00174","pdf_url":"https://www.frontiersin.org/articles/10.3389/fcimb.2019.00174/pdf","source":{"id":"https://openalex.org/S2506667490","display_name":"Frontiers in Cellular and Infection Microbiology","issn_l":"2235-2988","issn":["2235-2988"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Cellular and Infection Microbiology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fcimb.2019.00174/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035868691","display_name":"Joakim H\u00e5kansson","orcid":"https://orcid.org/0000-0002-4270-8475","observed_orcids":["https://orcid.org/0000-0002-4270-8475"]},"institutions":[{"id":"https://openalex.org/I2800664555","display_name":"RISE Research Institutes of Sweden","ror":"https://ror.org/03nnxqz81","country_code":"SE","type":"other","lineage":["https://openalex.org/I2800664555"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Joakim H\u00e5kansson","raw_affiliation_strings":["Division of Bioscience and Materials, RISE Research Institutes of Sweden, Bor\u00e5s, Sweden","RISE Research Institutes of Sweden (111 21 Stockholm - Su\u00e8de)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Bioscience and Materials, RISE Research Institutes of Sweden, Bor\u00e5s, Sweden","institution_ids":["https://openalex.org/I2800664555"]},{"raw_affiliation_string":"RISE Research Institutes of Sweden (111 21 Stockholm - Su\u00e8de)","institution_ids":["https://openalex.org/I2800664555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027555311","display_name":"Lovisa Ringstad","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800664555","display_name":"RISE Research Institutes of Sweden","ror":"https://ror.org/03nnxqz81","country_code":"SE","type":"other","lineage":["https://openalex.org/I2800664555"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Lovisa Ringstad","raw_affiliation_strings":["Division of Bioscience and Materials, RISE Research Institutes of Sweden, Bor\u00e5s, Sweden","RISE Research Institutes of Sweden (111 21 Stockholm - Su\u00e8de)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Bioscience and Materials, RISE Research Institutes of Sweden, Bor\u00e5s, Sweden","institution_ids":["https://openalex.org/I2800664555"]},{"raw_affiliation_string":"RISE Research Institutes of Sweden (111 21 Stockholm - Su\u00e8de)","institution_ids":["https://openalex.org/I2800664555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005039996","display_name":"Anita Monika Umerska","orcid":"https://orcid.org/0000-0002-4981-8247","observed_orcids":["https://orcid.org/0000-0002-4981-8247"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210112910","display_name":"Centre Hospitalier Universitaire d'Angers","ror":"https://ror.org/0250ngj72","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210112910"]},{"id":"https://openalex.org/I4210149833","display_name":"Universit\u00e9 Bretagne Loire","ror":"https://ror.org/04x1a4s97","country_code":"FR","type":"education","lineage":["https://openalex.org/I4210149833"]},{"id":"https://openalex.org/I4387153258","display_name":"Micro et Nanom\u00e9decines translationnelles","ror":"https://ror.org/055nbmz93","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I4387153258","https://openalex.org/I49451733"]},{"id":"https://openalex.org/I4387156376","display_name":"Cibles th\u00e9rapeutiques, formulation et expertise pr\u00e9clinique du m\u00e9dicament","ror":"https://ror.org/05adajg67","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4387156376","https://openalex.org/I90183372"]},{"id":"https://openalex.org/I49451733","display_name":"Universit\u00e9 d'Angers","ror":"https://ror.org/04yrqp957","country_code":"FR","type":"education","lineage":["https://openalex.org/I49451733"]},{"id":"https://openalex.org/I90183372","display_name":"Universit\u00e9 de Lorraine","ror":"https://ror.org/04vfs2w97","country_code":"FR","type":"education","lineage":["https://openalex.org/I90183372"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Anita Umerska","raw_affiliation_strings":["INSERM 1066, CNRS 6021, Universit\u00e9 Bretagne Loire, MINT, UNIV Angers, Angers, France","Universit\u00e9 de Lorraine, CITHEFOR, Nancy, France","CITHEFOR - Cibles th\u00e9rapeutiques, formulation et expertise pr\u00e9-clinique du m\u00e9dicament (UL, Campus Brabois Sant\u00e9, B\u00e2timent AB 1er \u00e9tage, 9 avenue de la For\u00eat de Haye, BP 20199, 54505 Vandoeuvre Les Nancy Cedex - France)","MINT - Micro et Nanom\u00e9decines Translationnelles (Universit\u00e9 d'Angers, MINT - CHU d'Angers, Institut de Biologie en Sant\u00e9, IRIS, 4 Rue Larrey - 49933 Angers CEDEX 09 - France)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM 1066, CNRS 6021, Universit\u00e9 Bretagne Loire, MINT, UNIV Angers, Angers, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I4210149833","https://openalex.org/I4387153258"]},{"raw_affiliation_string":"Universit\u00e9 de Lorraine, CITHEFOR, Nancy, France","institution_ids":["https://openalex.org/I4387156376","https://openalex.org/I90183372"]},{"raw_affiliation_string":"CITHEFOR - Cibles th\u00e9rapeutiques, formulation et expertise pr\u00e9-clinique du m\u00e9dicament (UL, Campus Brabois Sant\u00e9, B\u00e2timent AB 1er \u00e9tage, 9 avenue de la For\u00eat de Haye, BP 20199, 54505 Vandoeuvre Les Nancy Cedex - France)","institution_ids":["https://openalex.org/I4387156376"]},{"raw_affiliation_string":"MINT - Micro et Nanom\u00e9decines Translationnelles (Universit\u00e9 d'Angers, MINT - CHU d'Angers, Institut de Biologie en Sant\u00e9, IRIS, 4 Rue Larrey - 49933 Angers CEDEX 09 - France)","institution_ids":["https://openalex.org/I4210112910","https://openalex.org/I4387153258","https://openalex.org/I49451733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059141153","display_name":"Jenny Johansson","orcid":"https://orcid.org/0000-0001-7236-6472","observed_orcids":["https://orcid.org/0000-0001-7236-6472"]},"institutions":[{"id":"https://openalex.org/I2800664555","display_name":"RISE Research Institutes of Sweden","ror":"https://ror.org/03nnxqz81","country_code":"SE","type":"other","lineage":["https://openalex.org/I2800664555"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Jenny Johansson","raw_affiliation_strings":["Division of Bioscience and Materials, RISE Research Institutes of Sweden, Bor\u00e5s, Sweden","RISE Research Institutes of Sweden (111 21 Stockholm - Su\u00e8de)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Bioscience and Materials, RISE Research Institutes of Sweden, Bor\u00e5s, Sweden","institution_ids":["https://openalex.org/I2800664555"]},{"raw_affiliation_string":"RISE Research Institutes of Sweden (111 21 Stockholm - Su\u00e8de)","institution_ids":["https://openalex.org/I2800664555"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Therese Andersson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800664555","display_name":"RISE Research Institutes of Sweden","ror":"https://ror.org/03nnxqz81","country_code":"SE","type":"other","lineage":["https://openalex.org/I2800664555"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Therese Andersson","raw_affiliation_strings":["Division of Bioscience and Materials, RISE Research Institutes of Sweden, Bor\u00e5s, Sweden","RISE Research Institutes of Sweden (111 21 Stockholm - Su\u00e8de)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Bioscience and Materials, RISE Research Institutes of Sweden, Bor\u00e5s, Sweden","institution_ids":["https://openalex.org/I2800664555"]},{"raw_affiliation_string":"RISE Research Institutes of Sweden (111 21 Stockholm - Su\u00e8de)","institution_ids":["https://openalex.org/I2800664555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049066441","display_name":"Lukas Boge","orcid":"https://orcid.org/0000-0003-4742-1702","observed_orcids":["https://orcid.org/0000-0003-4742-1702"]},"institutions":[{"id":"https://openalex.org/I2800664555","display_name":"RISE Research Institutes of Sweden","ror":"https://ror.org/03nnxqz81","country_code":"SE","type":"other","lineage":["https://openalex.org/I2800664555"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Lukas Boge","raw_affiliation_strings":["Division of Bioscience and Materials, RISE Research Institutes of Sweden, Bor\u00e5s, Sweden","RISE Research Institutes of Sweden (111 21 Stockholm - Su\u00e8de)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Bioscience and Materials, RISE Research Institutes of Sweden, Bor\u00e5s, Sweden","institution_ids":["https://openalex.org/I2800664555"]},{"raw_affiliation_string":"RISE Research Institutes of Sweden (111 21 Stockholm - Su\u00e8de)","institution_ids":["https://openalex.org/I2800664555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065191830","display_name":"Ren\u00e9 T. Rozenbaum","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Ren\u00e9 T. Rozenbaum","raw_affiliation_strings":["Department of Biomedical Engineering, University of Groningen, University Medical Center Groningen, Groningen, Netherlands","UMCG - University Medical Center Groningen [Groningen] (PO box 30.001\r\n9700 RB Groningen - Pays-Bas)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering, University of Groningen, University Medical Center Groningen, Groningen, Netherlands","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]},{"raw_affiliation_string":"UMCG - University Medical Center Groningen [Groningen] (PO box 30.001\r\n9700 RB Groningen - Pays-Bas)","institution_ids":["https://openalex.org/I1334415907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035302871","display_name":"Prashant Kumar Sharma","orcid":"https://orcid.org/0000-0002-8342-8939","observed_orcids":["https://orcid.org/0000-0002-8342-8939"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Prashant K. Sharma","raw_affiliation_strings":["Department of Biomedical Engineering, University of Groningen, University Medical Center Groningen, Groningen, Netherlands","UMCG - University Medical Center Groningen [Groningen] (PO box 30.001\r\n9700 RB Groningen - Pays-Bas)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering, University of Groningen, University Medical Center Groningen, Groningen, Netherlands","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]},{"raw_affiliation_string":"UMCG - University Medical Center Groningen [Groningen] (PO box 30.001\r\n9700 RB Groningen - Pays-Bas)","institution_ids":["https://openalex.org/I1334415907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006893700","display_name":"Petter Tollb\u00e4ck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800664555","display_name":"RISE Research Institutes of Sweden","ror":"https://ror.org/03nnxqz81","country_code":"SE","type":"other","lineage":["https://openalex.org/I2800664555"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Petter Tollb\u00e4ck","raw_affiliation_strings":["Division of Bioscience and Materials, RISE Research Institutes of Sweden, Bor\u00e5s, Sweden","RISE Research Institutes of Sweden (111 21 Stockholm - Su\u00e8de)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Bioscience and Materials, RISE Research Institutes of Sweden, Bor\u00e5s, Sweden","institution_ids":["https://openalex.org/I2800664555"]},{"raw_affiliation_string":"RISE Research Institutes of Sweden (111 21 Stockholm - Su\u00e8de)","institution_ids":["https://openalex.org/I2800664555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052673794","display_name":"Camilla Bj\u00f6rn","orcid":"https://orcid.org/0000-0002-3034-6745","observed_orcids":["https://orcid.org/0000-0002-3034-6745","https://orcid.org/0000-0001-8032-9698"]},"institutions":[{"id":"https://openalex.org/I2800664555","display_name":"RISE Research Institutes of Sweden","ror":"https://ror.org/03nnxqz81","country_code":"SE","type":"other","lineage":["https://openalex.org/I2800664555"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Camilla Bj\u00f6rn","raw_affiliation_strings":["Division of Bioscience and Materials, RISE Research Institutes of Sweden, Bor\u00e5s, Sweden","RISE Research Institutes of Sweden (111 21 Stockholm - Su\u00e8de)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Bioscience and Materials, RISE Research Institutes of Sweden, Bor\u00e5s, Sweden","institution_ids":["https://openalex.org/I2800664555"]},{"raw_affiliation_string":"RISE Research Institutes of Sweden (111 21 Stockholm - Su\u00e8de)","institution_ids":["https://openalex.org/I2800664555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057987159","display_name":"Patrick Saulnier","orcid":"https://orcid.org/0000-0002-6408-3533","observed_orcids":["https://orcid.org/0000-0002-6408-3533"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210112910","display_name":"Centre Hospitalier Universitaire d'Angers","ror":"https://ror.org/0250ngj72","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210112910"]},{"id":"https://openalex.org/I4210149833","display_name":"Universit\u00e9 Bretagne Loire","ror":"https://ror.org/04x1a4s97","country_code":"FR","type":"education","lineage":["https://openalex.org/I4210149833"]},{"id":"https://openalex.org/I4387153258","display_name":"Micro et Nanom\u00e9decines translationnelles","ror":"https://ror.org/055nbmz93","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I4387153258","https://openalex.org/I49451733"]},{"id":"https://openalex.org/I49451733","display_name":"Universit\u00e9 d'Angers","ror":"https://ror.org/04yrqp957","country_code":"FR","type":"education","lineage":["https://openalex.org/I49451733"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Patrick Saulnier","raw_affiliation_strings":["INSERM 1066, CNRS 6021, Universit\u00e9 Bretagne Loire, MINT, UNIV Angers, Angers, France","MINT - Micro et Nanom\u00e9decines Translationnelles (Universit\u00e9 d'Angers, MINT - CHU d'Angers, Institut de Biologie en Sant\u00e9, IRIS, 4 Rue Larrey - 49933 Angers CEDEX 09 - France)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM 1066, CNRS 6021, Universit\u00e9 Bretagne Loire, MINT, UNIV Angers, Angers, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I4210149833","https://openalex.org/I4387153258"]},{"raw_affiliation_string":"MINT - Micro et Nanom\u00e9decines Translationnelles (Universit\u00e9 d'Angers, MINT - CHU d'Angers, Institut de Biologie en Sant\u00e9, IRIS, 4 Rue Larrey - 49933 Angers CEDEX 09 - France)","institution_ids":["https://openalex.org/I4210112910","https://openalex.org/I4387153258","https://openalex.org/I49451733"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001825767","display_name":"Margit Mahlapuu","orcid":"https://orcid.org/0000-0001-8740-8874","observed_orcids":["https://orcid.org/0000-0001-8740-8874"]},"institutions":[{"id":"https://openalex.org/I4210159742","display_name":"Promore Pharma (Sweden)","ror":"https://ror.org/05me5c114","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210159742"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Margit Mahlapuu","raw_affiliation_strings":["Promore Pharma AB, Solna, Sweden","Promore Pharma [Solna, Sweden] (Su\u00e8de)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Promore Pharma AB, Solna, Sweden","institution_ids":["https://openalex.org/I4210159742"]},{"raw_affiliation_string":"Promore Pharma [Solna, Sweden] (Su\u00e8de)","institution_ids":["https://openalex.org/I4210159742"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":12,"corresponding_author_ids":["https://openalex.org/A5001825767"],"corresponding_institution_ids":["https://openalex.org/I4210159742"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":6.891,"has_fulltext":true,"cited_by_count":87,"citation_normalized_percentile":{"value":0.98164755,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"9","issue":null,"first_page":"174","last_page":"174"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11103","display_name":"Antimicrobial Peptides and Activities","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11103","display_name":"Antimicrobial Peptides and Activities","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12526","display_name":"Antimicrobial agents and applications","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10771","display_name":"Wound Healing and Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antimicrobial-peptides","display_name":"antimicrobial peptides","score":0.9810000061988831},{"id":"https://openalex.org/keywords/topical-drug-delivery","display_name":"topical drug delivery","score":0.7609999775886536},{"id":"https://openalex.org/keywords/staphylococcus-aureus","display_name":"Staphylococcus aureus","score":0.968999981880188},{"id":"https://openalex.org/keywords/surgical-site-infection","display_name":"surgical site infection","score":0.9599999785423279},{"id":"https://openalex.org/keywords/wound-infection","display_name":"wound infection","score":0.8690000176429749},{"id":"https://openalex.org/keywords/poloxamer-gel","display_name":"poloxamer gel","score":0.9010000228881836},{"id":"https://openalex.org/keywords/lipid-nanocapsules","display_name":"lipid nanocapsules","score":0.9509999752044678},{"id":"https://openalex.org/keywords/cubosomes","display_name":"cubosomes","score":0.9990000128746033},{"id":"https://openalex.org/keywords/skin-irritation","display_name":"skin irritation","score":0.753000020980835},{"id":"https://openalex.org/keywords/skin-toxicity","display_name":"skin toxicity","score":0.3659999966621399}],"concepts":[{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.8224785327911377},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7694830894470215},{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.7390139102935791},{"id":"https://openalex.org/C204399865","wikidata":"https://www.wikidata.org/wiki/Q17157402","display_name":"Nanocapsules","level":3,"score":0.6451279520988464},{"id":"https://openalex.org/C540938839","wikidata":"https://www.wikidata.org/wiki/Q1201508","display_name":"Antimicrobial peptides","level":3,"score":0.5815818309783936},{"id":"https://openalex.org/C18150654","wikidata":"https://www.wikidata.org/wiki/Q17153796","display_name":"Nanocarriers","level":3,"score":0.5531769394874573},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5299991965293884},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.5030390620231628},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.4999275207519531},{"id":"https://openalex.org/C101335993","wikidata":"https://www.wikidata.org/wiki/Q408943","display_name":"Poloxamer","level":4,"score":0.4957967698574066},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4653303027153015},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.43537867069244385},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.41208717226982117},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3831658363342285},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35548925399780273},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1928020715713501},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.17960092425346375},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.153763085603714},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.10655391216278076},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09414881467819214},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.06921765208244324},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C15920480","wikidata":"https://www.wikidata.org/wiki/Q421281","display_name":"Copolymer","level":3,"score":0.0},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000099317","descriptor_name":"Hippo Kinases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000287","descriptor_name":"Administration, Topical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013203","descriptor_name":"Staphylococcal Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013203","descriptor_name":"Staphylococcal Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D013207","descriptor_name":"Staphylococcal Skin Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013211","descriptor_name":"Staphylococcus aureus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D013552","descriptor_name":"Swine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017346","descriptor_name":"Protein Serine-Threonine Kinases","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017346","descriptor_name":"Protein Serine-Threonine Kinases","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017346","descriptor_name":"Protein Serine-Threonine Kinases","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020442","descriptor_name":"Poloxamer","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D023181","descriptor_name":"Antimicrobial Cationic Peptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D023181","descriptor_name":"Antimicrobial Cationic Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D023422","descriptor_name":"Skin Irritancy Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053769","descriptor_name":"Nanocapsules","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":9,"locations":[{"id":"doi:10.3389/fcimb.2019.00174","doi":"https://doi.org/10.3389/fcimb.2019.00174","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fcimb.2019.00174","pdf_url":"https://www.frontiersin.org/articles/10.3389/fcimb.2019.00174/pdf","source":{"id":"https://openalex.org/S2506667490","display_name":"Frontiers in Cellular and Infection Microbiology","issn_l":"2235-2988","issn":["2235-2988"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Cellular and Infection Microbiology","raw_type":"journal-article"},{"id":"pmid:31192163","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31192163","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in cellular and infection microbiology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6548878","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6548878/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Cell Infect Microbiol","raw_type":"Text"},{"id":"pmh:oai:DiVA.org:ri-39066","doi":null,"is_oa":true,"landing_page_url":"http://urn.kb.se/resolve?urn=urn:nbn:se:ri:diva-39066","pdf_url":null,"source":{"id":"https://openalex.org/S4306401559","display_name":"KTH Publication Database DiVA (KTH Royal Institute of Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I86987016","host_organization_name":"KTH Royal Institute of Technology","host_organization_lineage":["https://openalex.org/I86987016"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:HAL:hal-02616068v1","doi":null,"is_oa":true,"landing_page_url":"https://univ-angers.hal.science/hal-02616068","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"https://www.frontiersin.org/articles/10.3389/fcimb.2019.00174/full","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:HAL:hal-02923028v1","doi":null,"is_oa":false,"landing_page_url":"https://hal.univ-lorraine.fr/hal-02923028","pdf_url":null,"source":{"id":"https://openalex.org/S4377196329","display_name":"HAL Portal Artxiker (Hindustan Aeronautics Limited (India))","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210088939","host_organization_name":"Hindustan Aeronautics Limited (India)","host_organization_lineage":["https://openalex.org/I4210088939"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ISSN: 2235-2988","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:a6fd761a81684aa59c942f6be65ae712","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/a6fd761a81684aa59c942f6be65ae712","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Cellular and Infection Microbiology, Vol 9 (2019)","raw_type":"article"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/e86fdac3-22cb-4e2d-83cf-e2037fa13723","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/files/85450225/fcimb_09_00174.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hakansson, J, Ringstad, L, Umerska, A, Johansson, J, Andersson, T, Boge, L, Rozenbaum, R T, Sharma, P K, Tollback, P, Bjorn, C, Saulnier, P & Mahlapuu, M 2019, 'Characterization of the in vitro, ex vivo, and in vivo Efficacy of the Antimicrobial Peptide DPK-060 Used for Topical Treatment', Frontiers in Cellular and Infection Microbiology, vol. 9, 174. https://doi.org/10.3389/fcimb.2019.00174","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/e86fdac3-22cb-4e2d-83cf-e2037fa13723","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/en/publications/e86fdac3-22cb-4e2d-83cf-e2037fa13723","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Cellular and Infection Microbiology, 9:174. Frontiers Media SA","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.3389/fcimb.2019.00174","doi":"https://doi.org/10.3389/fcimb.2019.00174","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fcimb.2019.00174","pdf_url":"https://www.frontiersin.org/articles/10.3389/fcimb.2019.00174/pdf","source":{"id":"https://openalex.org/S2506667490","display_name":"Frontiers in Cellular and Infection Microbiology","issn_l":"2235-2988","issn":["2235-2988"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Cellular and Infection Microbiology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1243669781","display_name":"Innovative Nanoformulation of Antimicrobial Peptides to Treat Bacterial Infectious Diseases","funder_award_id":"604182","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G3207356259","display_name":null,"funder_award_id":"2007\u20132013","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G393177772","display_name":null,"funder_award_id":"FP7 2007-2013","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G5702163051","display_name":null,"funder_award_id":"FP7/2007","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"}],"funders":[{"id":"https://openalex.org/F4320319774","display_name":"Universit\u00e9 Bretagne Loire","ror":null},{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320320893","display_name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","ror":"https://ror.org/02vjkv261"},{"id":"https://openalex.org/F4320325719","display_name":"Universit\u00e9 de Nantes","ror":"https://ror.org/03gnr7b55"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2947740772.pdf","grobid_xml":"https://content.openalex.org/works/W2947740772.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W1921625466","https://openalex.org/W1975494390","https://openalex.org/W1990310523","https://openalex.org/W1995882521","https://openalex.org/W2011731141","https://openalex.org/W2034011432","https://openalex.org/W2050895876","https://openalex.org/W2052570636","https://openalex.org/W2069791799","https://openalex.org/W2081156233","https://openalex.org/W2097099115","https://openalex.org/W2108979833","https://openalex.org/W2118899980","https://openalex.org/W2136130217","https://openalex.org/W2152230994","https://openalex.org/W2168787141","https://openalex.org/W2183808407","https://openalex.org/W2239738725","https://openalex.org/W2331308278","https://openalex.org/W2335377235","https://openalex.org/W2338977647","https://openalex.org/W2342937250","https://openalex.org/W2346303632","https://openalex.org/W2466748182","https://openalex.org/W2508787458","https://openalex.org/W2562261325","https://openalex.org/W2579968578","https://openalex.org/W2611768739","https://openalex.org/W2743060657","https://openalex.org/W2767698222","https://openalex.org/W2789853670","https://openalex.org/W2900942887","https://openalex.org/W2901389427"],"related_works":["https://openalex.org/W4316011066","https://openalex.org/W2520003375","https://openalex.org/W7078646448","https://openalex.org/W2041189201","https://openalex.org/W2419594751","https://openalex.org/W2064292930","https://openalex.org/W4398233391","https://openalex.org/W4388132349","https://openalex.org/W4410498203","https://openalex.org/W7204535231"],"abstract_inverted_index":{"Antimicrobial":[0],"peptides,":[1,7],"also":[2],"known":[3],"as":[4,11,39,41,84,86],"host":[5],"defense":[6],"have":[8],"recently":[9],"emerged":[10],"a":[12,73],"promising":[13],"new":[14],"category":[15],"of":[16,22,48,76,79,104,109,114,125,142,146,173,178],"therapeutic":[17],"agents":[18],"for":[19,58,169],"the":[20,28,42,122,126,129,147,152,159,170,179],"treatment":[21,172],"infectious":[23],"diseases.":[24],"This":[25],"study":[26,154],"evaluated":[27],"preclinical":[29],"in":[30,35,54,66,82,87,98,100,111,138,144],"vitro,":[31],"ex":[32,89],"vivo,":[33],"and":[34,97,165],"vivo":[36,90,101],"antimicrobial":[37,51],"activity,":[38],"well":[40,85],"potential":[43,124,160],"to":[44,140,161,181,184],"cause":[45],"skin":[46,96],"irritation,":[47],"human":[49],"kininogen-derived":[50],"peptide":[52,127,180],"DPK-060":[53,64,110,143,157],"different":[55,112],"formulations":[56,148],"designed":[57],"topical":[59,171],"delivery.":[60],"We":[61],"found":[62],"that":[63,156],"formulated":[65],"acetate":[67],"buffer":[68],"or":[69,117],"poloxamer":[70],"gel":[71],"caused":[72],"marked":[74],"reduction":[75],"bacterial":[77],"counts":[78],"Staphylococcus":[80],"aureus":[81],"vitro":[83],"an":[88,99,163],"wound":[91],"infection":[92],"model":[93,103],"using":[94],"pig":[95],"mouse":[102],"surgical":[105],"site":[106],"infection.":[107],"Encapsulation":[108],"types":[113],"lipid":[115],"nanocapsules":[116],"cubosomes":[118],"did":[119],"not":[120],"improve":[121],"bactericidal":[123],"under":[128],"applied":[130],"test":[131],"conditions.":[132],"No":[133],"dermal":[134],"irritation":[135],"was":[136],"observed":[137],"response":[139],"administration":[141],"any":[145,186],"tested.":[149],"In":[150],"conclusion,":[151],"present":[153],"confirms":[155],"has":[158],"be":[162],"effective":[164],"safe":[166],"drug":[167],"candidate":[168],"microbial":[174],"infections;":[175],"however,":[176],"adsorption":[177],"nanocarriers":[182],"failed":[183],"show":[185],"additional":[187],"benefits.":[188]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":15},{"year":2024,"cited_by_count":13},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":16},{"year":2021,"cited_by_count":16},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2019-06-07T00:00:00"}